FTIOP
REGN icon

Fiduciary Trust International of Pennsylvania’s Regeneron Pharmaceuticals REGN Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-455
Closed -$247K – 302
2015
Q4 		$247K Buy
455
+15
+3% +$8.13K 0.02% 268
2015
Q3 		$205K Sell
440
-75
-15% -$40.3K 0.02% 288
2015
Q2 		$263K Buy
+515
New +$251K 0.02% 346

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's REGN Position: Q1 2016 in Review

Fiduciary Trust International of Pennsylvania sold out of Regeneron Pharmaceuticals (REGN) in Q1 2016, closing a stake of 455 shares — an estimated $247K sold.

Fiduciary Trust International of Pennsylvania first reported a position in REGN in Q2 2015 and held it in 3 quarters. The position peaked at $263K in Q2 2015. 550 funds tracked by Wall St. Rank hold REGN as of Q1 2016.

  • Fiduciary Trust International of Pennsylvania reported no remaining Regeneron Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Fiduciary Trust International of Pennsylvania sold 455 Regeneron Pharmaceuticals shares in Q1 2016, an estimated $247K.
  • Fiduciary Trust International of Pennsylvania first reported a position in Regeneron Pharmaceuticals in Q2 2015 and held it in 3 quarters.
  • Fiduciary Trust International of Pennsylvania's Regeneron Pharmaceuticals position peaked at $263K in Q2 2015.
  • 550 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2016.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q1 2016, filed 13 May 2016.